SSO is pleased to announce the availability of two Clinical Investigator Awards: an any topic CIA and a second CIA opportunity available due to the generous support of the Appendix Cancer Pseudomyxoma Peritonei Research Foundation (ACPMP).
Clinical Investigator Award 2025-2027
- Any Topic
- Supported by SSO
Lisa Kurtz Luciano Appendix Cancer and Pseudomyxoma Peritonei Clinical Investigator Award 2025-2027
- Appendix Cancer Pseudomyxoma Peritonei (PMP): Proposals related to appendiceal mucinous neoplasms, appendiceal adenocarcinomas (including signet ring cell adenocarcinoma and goblet cell adenocarcinoma), and/or PMP of appendiceal origin; with a special interest in proposals that embrace moving this rare malignant tumor type forward to a curative science.
- Support by a grant from ACPMP
Clinical Investigator Awards promote patient-focused research conducted by surgical oncologists in clinical and translational science. Awards are funded for two years at $50,000/year for a total award of $100,000 beginning May 1 of the award year and concluding April 31 of the 2nd year. (Example: May 1, 2025-April 30, 2027). Applicants may apply more than once but may only receive the award one time.
Eligibility
- Must be a surgical oncologist within eight (8) years of completion of fellowship or related training.
- Must be an SSO U.S. member in good standing for at least six (6) months prior to application submission to be eligible for an award.
See Call for Proposals for detailed application rules and guidance.